The landscape of dementia diagnosis has developed considerably with the arrival of innovative biomarkers, which include amyloid PET scans, tau imaging, and blood-dependent assessments that will detect Alzheimer's pathology many years prior to symptoms arise. Even though these technological developments represent extraordinary development in knowing neurodegenerative diseases, they may... https://clarenceo531nxi1.blogozz.com/profile